OOIR: Observatory of International Research

Papers

(The TQCC of Therapeutic Advances in Endocrinology and Metabolism is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
GLP-1 receptor agonists: an updated review of head-to-head clinical studies	146
Should metformin remain the first-line therapy for treatment of type 2 diabetes?	75
MAFLD: a multisystem disease	57
Role of inflammation in diabetic cardiomyopathy	37
Cardiovascular risk in menopausal women and our evolving understanding of menopausal hormone therapy: risks, benefits, and current guidelines for use	37
Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis	34
The potential role of incretin-based therapies for polycystic ovary syndrome: a narrative review of the current evidence	32
Insulin resistance in transgender individuals correlates with android fat mass	28
Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection	24
Sodium-glucose cotransporter-2 inhibitors (SGLT2i) in kidney transplant recipients: what is the evidence?	23
Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data	22
Advancements in the treatment of differentiated thyroid cancer	20
NAFLD in type 1 diabetes: overrated or underappreciated?	20
Diabetes clinic reinvented: will technology change the future of diabetes care?	20
Clinical approaches to treat impaired awareness of hypoglycaemia	19
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications	18
The importance of physical activity in management of type 2 diabetes and COVID-19	18
Medullary thyroid carcinoma: recent advances in identification, treatment, and prognosis	17
Current updates on protein as biomarkers for diabetic kidney disease: a systematic review	16
Endotrophin as a novel marker in PCOS and its relation with other adipokines and metabolic parameters: a pilot study	16
Therapeutics for type-2 diabetes mellitus: a glance at the recent inclusions and novel agents under development for use in clinical practice	15
Body composition and cardiometabolic health of pediatric patients with X-linked hypophosphatemia (XLH) under burosumab therapy	15
Digital health and diabetes: experience from India	15
Calcitonin: current concepts and differential diagnosis	15
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease	15

The potential of GLP-1 receptor agonists in type 2 diabetes and chronic kidney disease: from randomised trials to clinical practice	14
Alteration of serum neuregulin 4 and neuregulin 1 in gestational diabetes mellitus	14
Pharmacotherapy to delay the progression of diabetic kidney disease in people with type 2 diabetes: past, present and future	14
Recent advancement in the treatment of boys and adolescents with hypogonadism	13
Low complication rates of testosterone and estradiol implants for androgen and estrogen replacement therapy in over 1 million procedures	13
Bone health in transgender people: a narrative review	13
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes	12
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective	12
Update on genetics and epigenetics in metabolic associated fatty liver disease	11
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity	11
Primary aldosteronism subtyping in the setting of partially successful adrenal vein sampling	10
Therapeutic approaches for non-alcoholic steatohepatitis	10
The effect of specific binding proteins on immunoassay measurements of total and free thyroid hormones and cortisol	10
Potential immunological effects of gender-affirming hormone therapy in transgender people – an unexplored area of research	9
Should denosumab treatment for osteoporosis be continued indefinitely?	9
Pharmacological management of severe Cushing’s syndrome: the role of etomidate	9
Menopause, androgens, and cardiovascular ageing: a narrative review	9
RANKL inhibition: a new target of treating diabetes mellitus?	9
Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome	9
Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clinic	9